BlueRock, Vertex vet Hei becomes CTO at Clade

Clade Therapeutics Inc., which is developing off-the-shelf stem cell therapies, hired Derek Hei as CTO. Hei was SVP of preclinical and clinical manufacturing, cell and gene therapies at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), and previously was chief of manufacturing and technical operations at BlueRock Therapeutics LP.

Scott Saywell became CBO at Herophilus, where he will oversee strategic partnerships that enable the identification of targets and therapies for neurodevelopmental, psychiatric, and neurodegenerative disorders. Saywell held several senior roles at Theravance Biopharma Inc. (NASDAQ:TBPH), most recently VP of corporate development and strategy...